id	domain	url
cswr-12193	doi.org	https://doi.org/10.1016/j.ccm.2022.06.014
cswr-12193	cysticfibrosisnewstoday.com	https://cysticfibrosisnewstoday.com/31-days-of-cf/31-days-of-cfthe-unexpected-side-of-trikafta/?cn-reloaded=1
cswr-12193	doi.org	https://doi.org/10.1542
cswr-12193	www.cbsnews.com	https://www.cbsnews.com/news/what-happens-when-someone-losesdisability-insurance
cswr-12193	grc.osu.edu	https://grc.osu.edu/sites/default/files/inline-files
cswr-12193	www.cff.org	https://www.cff.org/intro-cf
cswr-12193	www.cff.org	https://www.cff.org/support
cswr-12193	www.cff.org	https://www.cff.org
cswr-12193	www.cff.org	https://www.cff.org
cswr-12193	www.cff.org	https://www.cff.org/managingcf/cf-care-center-visits
cswr-12193	www.cff.org	https://www.cff.org/news/2020-11/cf-foundation-seeks-inputcommunities-color
cswr-12193	doi.org	https://doi.org/10.1007/s10880-021-09825-w
cswr-12193	www.brookings.edu	https://www.brookings.edu/articles/governmentregulated-or-negotiated-drug-prices-key-design-considerations
cswr-12193	doi.org	https://doi.org/10.1016/j
cswr-12193	www	http://ezproxy.cul.columbia.edu/login?url=https://www
cswr-12193	doi.org	https://doi.org/10.1177/2374373521996971
cswr-12193	doi.org	https://doi.org/10.1016/j.jcf.2023.02.004
cswr-12193	doi.org	https://doi.org/10.1007/s00127-022-02307-w
cswr-12193	cysticfibrosisnewstoday.com	https://cysticfibrosisnewstoday.com/cysticfibrosis/trikafta-very-effective-cf-therapy-but-still-too-costly-icer-reports
cswr-12193	doi.org	https://doi.org/10.1007/s11606-019-05439-z
cswr-12193	doi.org	https://doi.org/10.1002/ppul.26318
cswr-12193	doi.org	https://doi.org/10.1177/0961463x16631765
cswr-12193	www.ssa.gov	https://www.ssa.gov/ssi/text-redets-ussi.htm
cswr-12193	www.ssa.gov	https://www.ssa.gov/ssi/text-cdrs-ussi
cswr-12193	www.ssa.gov	https://www.ssa.gov/ssi/text-disableussi.htm#sgact
cswr-12193	www.ssa.gov	www.ssa.gov/disability/professionals/bluebook
cswr-12193	www.ssa.gov	https://www.ssa.gov/disability/professionals/procontacts.htm
cswr-12193	www.ssa.gov	https://www.ssa.gov/benefits/disability/work.html
cswr-12193	www.fda.gov	https://www.fda.gov/news-events/pressannouncements/fda-approves-new-breakthrough-therapy-cystic-fibrosis
cswr-12193	doi.org	https://doi.org/10.1037/cpp0000256
cswr-12193	cysticfibrosisnewstoday.com	https://cysticfibrosisnewstoday.com/news
cswr-12193	doi.org	https://doi.org/10.3389/fphar.2023.1163391
cswr-12193	doi.org	https://doi.org/10.1177/17534666221144211